Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Asymchem Laboratories Receives Tianjin Science And Technology Innovation Funds

This article was originally published in PharmAsia News

Executive Summary

Asymchem Laboratories (Tianjin) has been included in Tianjin city's 2008 science and technology innovation funds awards(Mayor's Funds) for its project on internationally-compliant key technology research in raw materials drug production. The firm will receive RMB 70 million for technology innovation achievements. Asymchem Laboratories will be China's first pharmaceutical company that incorporates R&D, scalable production and comprehensive testing services for international standards for drug raw materials. The project, which began in November and is scheduled for completion in September 2010, will bring considerable economic benefits to Tianjin. (Click here for more - Chinese Language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts